“Autologous vs. Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Follicular Non-Hodgkins Lymphoma (FL) Beyond First Complete Response or First Partial Response”, in American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2008.
, “Informed Consent: Improving the Form and the Process”, in PRIM&R: Public Responsibility in Medicine and Research, National Harbor, MD, 2011.
, “Easy-to-Read Informed Consent Forms for Hematopoietic Cell Transplant Clinical Trials”, Biol Blood Marrow Transplant, vol. 18, pp. 183-189, 2012.
, “Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels”, Biol Blood Marrow Transplant, vol. 18, pp. 1007-1011, 2012.
, “Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402”, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
, “Exercise and Stress Management Training Prior to Hematopoietic Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902”, Biol Blood Marrow Transplant, vol. 20, pp. 1530-1536, 2014.
, “Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care In Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome*”, Biol Blood Marrow Transplant, vol. 20, pp. 1566-1572, 2014.
, “Phase 3 Clinical trial of Steroids/Mycophenolate Mofetil vs Steroids/Placebo as Therapy for Acute GVHD: BMT CTN 0802”, Blood, vol. 124, pp. 3221-3227, 2014.
, “Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol”, Biol Blood Marrow Transplant, vol. 20, pp. 858-864, 2014.
, “Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)”, Biol Blood Marrow Transplant, 2014.
“Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT”, Blood, vol. 124, pp. 1372-1377, 2014.
,